Hepatitis Current Events | Hepatitis News | 6
|
| Page
6 of
11 |
218 Results |
|
|
|
Sort By:
Page Views | Date |
EU research fights killer viruses' stubborn resistance to drugs
Viruses' growing resistance to drugs means diseases such as hepatitis B and C are increasingly difficult to treat. New pandemics may arise with unforeseeable consequences. The EU is therefore contributing EUR9 million to the "Vigilance against Viral Resistance" (VIRGIL) project, to be launched today in Lyon (France). It will start by... view more... (2004-06-29)
Widely used hepatitis B drug spurs HIV drug resistance
A Johns Hopkins study has proven false established medical practice that an antiretroviral drug widely used to treat hepatitis B liver infections was safe to use on its own in patients co-infected with HIV. view more (2007-03-01)
Leeds research points to new therapy for hepatitis C treatment
Combination therapies similar to those used for HIV patients may be the best way of treating hepatitis C virus (HCV), say researchers from the University of Leeds. view more (2008-12-09)
The prevalence of hepatitis B virus infection in inflammatory bowel disease patients
Patients with IBD have high risk of infection by hepatitis viruses B or C because during the course of their disease, they need blood transfusions, and sometimes surgical and endoscopic procedures for diagnosis and treatment. view more (2008-09-18)
Focusing HIV treatment helps control concurrent hepatitis B infection
Prolonged use of highly active antiretroviral therapy (HAART) to treat people infected with both HIV and hepatitis B (HBV) helps to better control the hepatitis B infection and could delay or prevent liver complications. view more (2009-07-15)
New test helps identify hepatitis C patients at high risk of developing cirrhosis
A researcher at the Stanford University School of Medicine has helped confirm the reliability of a new test for liver disease that is ushering in the long-promised era of personalized medicine based on each individual's genetic makeup. view more (2007-04-27)
New test helps identify hepatitis C patients at high risk of developing cirrhosis
A researcher at the Stanford University School of Medicine has helped confirm the reliability of a new test for liver disease that is ushering in the long-promised era of personalized medicine based on each individual's genetic makeup. view more (2007-04-30)
Researcher studies, treats military with 'silent disease'
For nearly four years, a researcher in Washington, D.C., has been working toward tracking how servicemembers respond to treatment for the "silent disease" hepatitis C. view more (2006-07-10)
NEJM Study Points to New Era in Hepatitis C Treatment
For patients with the most common form of hepatitis C, the addition of a hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances of being cured, and it does it in half the time of standard therapy alone. view more (2009-06-08)
Largest-ever database for liver proteins may lead to treatments for hepatitis
Scientists at a group of 11 research centers in China are reporting for the first time assembly of the largest-ever collection of data about the proteins produced by genes in a single human organ. view more (2009-11-12)
Study Highlights Need For Hepatitis C Vaccine (pp 1452, 1478)
A US study in this week's issue of THE LANCET highlights a high rate of hepatitis C virus (HCV) infection among injection-drug users, and that immunity against persistent HCV infection can be acquired. The authors suggest that vaccines should be tested to reduce the burden of liver disease associated with HCV infection. Around 4 million people in... view more... (2002-04-24)
Nano vaccine for hepatitis B shows promise for third world
Chronic hepatitis B infects 400 million people worldwide, many of them children. Even with three effective vaccines available, hepatitis B remains a stubborn, unrelenting health problem, especially in Africa and other developing areas. view more (2008-08-13)
NDRI researchers report on transitions to injecting drug use among noninjecting heroin users
In a study reported in the current issue of the Journal of Acquired Immune Deficiency Syndromes, scientists from the National Development and Research Institutes, Inc. (NDRI) report on a study of street-recruited heroin users in New York City, who were not injecting, to determine the incidence and predictors of making a transition to injecting. view more (2006-05-08)
Hepatitis C helicase unwinds DNA in a spring-loaded, 3-step process
The process by which genes are duplicated is mysterious and complex, involving a cast of characters with diverse talents and the ability to play well with others in extremely close quarters. view more (2007-07-27)
New biomarker predicts response to hepatitis C treatment
Researchers have identified the first genetic marker that predicts response to hepatitis C treatments, and a single letter of DNA code appears to make a huge difference. view more (2009-08-17)
Wistar researchers invigorate 'exhausted' immune cells
In battles against chronic infections, the body's key immune cells often become exhausted and ineffective. Researchers at The Wistar Institute have found a way to restore vigor to these killer T cells by blocking a key receptor on their surface, findings that may advance the development of new therapies for diseases such as HIV, hepatitis B and C,... view more... (2008-09-16)
Mayo Clinic's new imaging technology accurately identifies a broad spectrum of liver disease
A new study shows that an imaging technology developed by Mayo Clinic researchers can identify liver fibrosis with high accuracy and help eliminate the need for liver biopsies. Liver fibrosis is a common condition that can lead to incurable cirrhosis if not treated in time. view more (2008-11-03)
Hepatitis B drug can compromise HIV treatment
Treating hepatitis B patients with the drug entecavir can cause those who are also infected with HIV to become resistant to two of the most important drugs in the anti-HIV arsenal. view more (2007-06-21)
Acellular pertussis vaccine proves effective in adults, adolescents
A vaccine to protect adults and adolescents against illness due to Bordetella pertussis infection-or whooping cough-has proved more than 90 percent effective in a national, large-scale clinical study. view more (2005-10-13)
Transplants In HIV Patients Should Proceed But Drug Interactions Can Be Concern, Concludes Research At International Congress Of The Transplantation Society
While historically surgeons have been reluctant to transplant patients with the human immunodeficiency virus (HIV), in recent years, some centers have begun to accept patients with well-controlled HIV as candidates for liver or kidney transplantation. Based on results of three studies from the United States and one from France, which collectively... view more... (2002-08-20)
|
|
| Page
6 of
11 |
218 Results |
|
|
|
Sort By:
Page Views | Date |
|
